Jim Simons Poly Pid Ltd. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.34 - $0.45 $9,795 - $12,964	28,810 New	28,810 $11,000
Q2 2022 Aug 12, 2022	SELL	$4.35 - $5.76 $57,480 - $76,112	-13,214 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.92 - $6.25 $51,798 - $82,587	13,214 New	13,214 $72,000
Q3 2021 Nov 12, 2021	SELL	$7.05 - $9.48 $135,282 - $181,911	-19,189 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.4 - $9.99 $161,187 - $191,698	19,189 New	19,189 $174,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $69.6M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.